Normocalcemic versus Hypercalcemic Primary Hyperparathyroidism: More Stone than Bone?

Table 1

Baseline characteristics of study patients.

Variable	Normocalcemic	Hypercalcemic	Total	𝑃 value
Gender
Male %	21.2	24.3	22.9	𝑃=0.757
Female %	78.8	75.7	77.1
Age (years)	63.67 ± 13.83	61.68 ± 13.86	62.61 ± 13.78	𝑃=0.550
BMI (Kg/m²)	25.78 ± 3.85	26.66 ± 4.25	26.25 ± 4.06	𝑃=0.376
Serum calcium  (mg/dL)	9.58 ± 0.44	11.33 ± 0.90	10.51 ± 1.13	𝑃<0.001
Serum creatinine (mg/dL)	0.89 ± 0.20	0.85 ± 0.32	0.86 ± 0.29	𝑃=0.676
Serum 25OHD (ng/mL)	42.45 ± 12.94	30.91 ± 10.63	36.68 ± 13.11	𝑃<0.001
Serum PTH (pg/mL)	127.52 ± 114.41	226.18 ± 398.61	179.67 ± 302.38	𝑃=0.175
Serum CTX (pg/mL)	342.94 ± 207.16	492.13 ± 425.37	416.39 ± 338.75	𝑃=0.080
CrCL (mL/min/1,73)	80.08 ± 21.08	87.82 ± 34.17	84.17 ± 28.82	𝑃=0.253

Data expressed as mean ± SD.